| cyclosporine, modified 25 MG Oral Capsule [Neoral] cyclosporine, modified | 120 | 2.4%
| T3 | 100% | 492,479 |
| cyclosporine, modified 100 MG Oral Capsule [Neoral] cyclosporine, modified | 120 | 2.4%
| T3 | 100% | 492,479 |
| 1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng] satralizumab-mwge | 120 | 2.4%
| T4 | 100% | 220 |
| sebetralstat 300 MG Oral Tablet [Ekterly] sebetralstat | 120 | 2.4%
| T4 | 60% | - |
| buspirone hydrochloride 15 MG Oral Capsule [Bucapsol] buspirone hydrochloride | 119 | 2.3%
| T5 | 0% | 1,420,432 |
| doxycycline hyclate 200 MG Delayed Release Oral Tablet doxycycline hyclate | 118 | 2.3%
| T2 | 0% | 4,121,486 |
| estradiol 0.1 MG/ML Vaginal Cream [Estrace] estradiol | 118 | 2.3%
| T2 | 0% | 1,289,816 |
| tretinoin 0.25 MG/ML Topical Cream [Retin-A] tretinoin | 117 | 2.3%
| T2 | 66.7% | 91,688 |
| tretinoin 0.5 MG/ML Topical Cream [Retin-A] tretinoin | 117 | 2.3%
| T2 | 66.7% | 91,688 |
| tretinoin 1 MG/ML Topical Cream [Retin-A] tretinoin | 117 | 2.3%
| T2 | 66.7% | 91,688 |
| tretinoin 0.00025 MG/MG Topical Gel [Retin-A] tretinoin | 117 | 2.3%
| T2 | 66.7% | 91,688 |
| tretinoin 0.0001 MG/MG Topical Gel [Retin-A] tretinoin | 117 | 2.3%
| T2 | 66.7% | 91,688 |
| glycopyrrolate 1.5 MG Oral Tablet glycopyrrolate | 117 | 2.3%
| T2 | 0% | 51,524 |
| 1.14 ML sarilumab 132 MG/ML Auto-Injector [Kevzara] sarilumab | 117 | 2.3%
| T4 | 100% | 4,167 |
| efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi] efavirenz | 117 | 2.3%
| T4 | 0% | 1,779 |
| 12 HR carbamazepine 100 MG Extended Release Oral Capsule [Carbatrol] carbamazepine | 117 | 2.3%
| T2 | 0% | 1,707 |
| 12 HR carbamazepine 200 MG Extended Release Oral Capsule [Carbatrol] carbamazepine | 117 | 2.3%
| T2 | 0% | 1,707 |
| 12 HR carbamazepine 300 MG Extended Release Oral Capsule [Carbatrol] carbamazepine | 117 | 2.3%
| T2 | 0% | 1,707 |
| 0.574 ML zilucoplan 40 MG/ML Prefilled Syringe [Zilbrysq] zilucoplan | 116 | 2.3%
| T4 | 100% | - |
| 0.81 ML zilucoplan 40 MG/ML Prefilled Syringe [Zilbrysq] zilucoplan | 116 | 2.3%
| T4 | 100% | - |
| hydrocortisone 1 MG/ML Oral Solution [Khindivi] hydrocortisone | 115 | 2.3%
| T5 | 0% | 1,257,661 |
| indomethacin 50 MG Rectal Suppository [Indocin] indomethacin | 115 | 2.3%
| T5 | 0% | 123,532 |
| halobetasol propionate 0.5 MG/ML Topical Foam halobetasol propionate | 115 | 2.3%
| T4 | 0% | 89,868 |
| 168 HR estradiol 0.00208 MG/HR Transdermal System [Climara] estradiol | 115 | 2.3%
| T2 | 0% | 6,601 |
| 168 HR estradiol 0.00417 MG/HR Transdermal System [Climara] estradiol | 115 | 2.3%
| T2 | 0% | 6,601 |
| 168 HR estradiol 0.00312 MG/HR Transdermal System [Climara] estradiol | 115 | 2.3%
| T2 | 0% | 6,601 |
| 168 HR estradiol 0.00104 MG/HR Transdermal System [Climara] estradiol | 115 | 2.3%
| T2 | 0% | 6,601 |
| 168 HR estradiol 0.00156 MG/HR Transdermal System [Climara] estradiol | 115 | 2.3%
| T2 | 0% | 6,601 |
| 168 HR estradiol 0.0025 MG/HR Transdermal System [Climara] estradiol | 115 | 2.3%
| T2 | 0% | 6,601 |
| diflunisal 375 MG Oral Tablet [Dolobid] diflunisal | 115 | 2.3%
| T5 | 0% | 3,325 |
| flurandrenolide 0.004 MG/SQCM Medicated Tape [Cordran] flurandrenolide | 115 | 2.3%
| T4 | 0% | 1,839 |
| tasimelteon 4 MG/ML Oral Suspension [Hetlioz] tasimelteon | 115 | 2.3%
| T4 | 100% | 499 |
| tiopronin 100 MG Oral Tablet [Thiola] tiopronin | 115 | 2.3%
| T5 | 0% | 261 |
| sarecycline 100 MG Oral Tablet [Seysara] sarecycline | 115 | 2.3%
| T5 | 0% | 190 |
| birch triterpenes 0.1 MG/MG Topical Gel [Filsuvez] birch triterpenes | 115 | 2.3%
| T4 | 100% | - |
| 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] minocycline | 115 | 2.3%
| T5 | 0% | - |
| berotralstat 150 MG Oral Capsule [Orladeyo] berotralstat | 113 | 2.2%
| T5 | 100% | 158 |
| berotralstat 110 MG Oral Capsule [Orladeyo] berotralstat | 113 | 2.2%
| T5 | 100% | 158 |
| palovarotene 1 MG Oral Capsule [Sohonos] palovarotene | 113 | 2.2%
| T4 | 100% | - |
| palovarotene 1.5 MG Oral Capsule [Sohonos] palovarotene | 113 | 2.2%
| T4 | 100% | - |
| palovarotene 2.5 MG Oral Capsule [Sohonos] palovarotene | 113 | 2.2%
| T4 | 100% | - |
| palovarotene 5 MG Oral Capsule [Sohonos] palovarotene | 113 | 2.2%
| T4 | 100% | - |
| palovarotene 10 MG Oral Capsule [Sohonos] palovarotene | 113 | 2.2%
| T4 | 100% | - |
| 24 HR amantadine 68.5 MG Extended Release Oral Capsule [Gocovri] amantadine | 112 | 2.2%
| T4 | 88.2% | 4,464 |
| 24 HR amantadine 137 MG Extended Release Oral Capsule [Gocovri] amantadine | 112 | 2.2%
| T4 | 88.2% | 4,464 |
| {2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity]) } Pack [Evenity 210 MG Dose] romosozumab-aqqg | 112 | 2.2%
| T4 | 100% | 145 |
| 60 ACTUAT exenatide 0.005 MG/ACTUAT Pen Injector | 112 | 2.2%
| T3 | 100% | - |
| 60 ACTUAT exenatide 0.01 MG/ACTUAT Pen Injector | 112 | 2.2%
| T3 | 100% | - |
| {18 (oteseconazole 150 MG Oral Capsule [Vivjoa]) } Pack [Vivjoa 18-Count] oteseconazole | 109 | 2.2%
| T4 | 100% | 71 |
| lusutrombopag 3 MG Oral Tablet [Mulpleta] lusutrombopag | 109 | 2.2%
| T5 | 100% | 28 |
| fluticasone propionate 0.5 MG/ML Topical Lotion fluticasone propionate | 108 | 2.1%
| T2 | 0% | 4,902,813 |
| 1.14 ML sarilumab 132 MG/ML Prefilled Syringe [Kevzara] sarilumab | 108 | 2.1%
| T4 | 100% | 4,167 |
| 1.14 ML sarilumab 175 MG/ML Prefilled Syringe [Kevzara] sarilumab | 108 | 2.1%
| T4 | 100% | 4,167 |
| 1.14 ML sarilumab 175 MG/ML Auto-Injector [Kevzara] sarilumab | 108 | 2.1%
| T4 | 100% | 4,167 |
| sirolimus 0.002 MG/MG Topical Gel [Hyftor] sirolimus | 107 | 2.1%
| T5 | 100% | 7,218 |
| 12 HR hydrocodone bitartrate 10 MG Extended Release Oral Capsule hydrocodone bitartrate | 107 | 2.1%
| T4 | 28.6% | - |
| 12 HR hydrocodone bitartrate 15 MG Extended Release Oral Capsule hydrocodone bitartrate | 107 | 2.1%
| T4 | 28.6% | - |
| 12 HR hydrocodone bitartrate 20 MG Extended Release Oral Capsule hydrocodone bitartrate | 107 | 2.1%
| T4 | 28.6% | - |
| 12 HR hydrocodone bitartrate 30 MG Extended Release Oral Capsule hydrocodone bitartrate | 107 | 2.1%
| T4 | 28.6% | - |
| 12 HR hydrocodone bitartrate 40 MG Extended Release Oral Capsule hydrocodone bitartrate | 107 | 2.1%
| T4 | 28.6% | - |
| 12 HR hydrocodone bitartrate 50 MG Extended Release Oral Capsule hydrocodone bitartrate | 107 | 2.1%
| T4 | 28.6% | - |
| riluzole 5 MG/ML Oral Suspension [Tiglutik] riluzole | 106 | 2.1%
| T3 | 42.1% | 9,582 |
| benzoyl peroxide 0.025 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel benzoyl peroxide | 106 | 2.1%
| T2 | 0% | 465 |
| metreleptin 5 MG/ML Injectable Solution [Myalept] metreleptin | 106 | 2.1%
| T5 | 100% | 13 |
| 0.416 ML zilucoplan 40 MG/ML Prefilled Syringe [Zilbrysq] zilucoplan | 106 | 2.1%
| T4 | 100% | - |
| doxycycline hyclate 50 MG Delayed Release Oral Tablet doxycycline hyclate | 105 | 2.1%
| T2 | 0% | 4,121,486 |
| doxycycline hyclate 100 MG Delayed Release Oral Tablet doxycycline hyclate | 105 | 2.1%
| T3 | 0% | 4,121,486 |
| betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment betamethasone | 105 | 2.1%
| T4 | 21.4% | 407,711 |
| mesna 400 MG Oral Tablet [Mesnex] mesna | 105 | 2.1%
| T5 | 0% | 284 |
| 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler [Xopenex] | 105 | 2.1%
| T3 | 0% | - |
| cyclosporine 25 MG Oral Capsule [Sandimmune] cyclosporine | 104 | 2.1%
| T3 | 100% | 492,479 |
| cyclosporine 100 MG Oral Capsule [Sandimmune] cyclosporine | 104 | 2.1%
| T4 | 100% | 492,479 |
| tacrolimus 0.5 MG Oral Capsule [Prograf] tacrolimus | 104 | 2.1%
| T3 | 100% | 204,385 |
| tacrolimus 1 MG Oral Capsule [Prograf] tacrolimus | 104 | 2.1%
| T3 | 100% | 204,385 |
| tacrolimus 5 MG Oral Capsule [Prograf] tacrolimus | 104 | 2.1%
| T4 | 100% | 204,385 |
| apraclonidine 10 MG/ML Ophthalmic Solution [Iopidine] apraclonidine | 104 | 2.1%
| T4 | 0% | 1,543 |
| mycophenolic acid 180 MG Delayed Release Oral Tablet [Myfortic] mycophenolic acid | 104 | 2.1%
| T3 | 100% | 215 |
| 0.5 ML ustekinumab-hmny 90 MG/ML Prefilled Syringe [Starjemza] ustekinumab-hmny | 104 | 2.1%
| T3 | 100% | - |
| 0.5 ML ustekinumab-hmny 90 MG/ML Injection [Starjemza] ustekinumab-hmny | 104 | 2.1%
| T3 | 100% | - |
| tobramycin 60 MG/ML Inhalation Solution [Kitabis] tobramycin | 103 | 2%
| T4 | 100% | 195,319 |
| naloxone 0.5 MG / pentazocine 50 MG Oral Tablet naloxone | 102 | 2%
| T2 | 5.9% | 744,446 |
| mycophenolic acid 360 MG Delayed Release Oral Tablet [Myfortic] mycophenolic acid | 102 | 2%
| T4 | 100% | 215 |
| almotriptan 6.25 MG Oral Tablet almotriptan | 100 | 2%
| T3 | 0% | 1,289 |
| almotriptan 12.5 MG Oral Tablet almotriptan | 100 | 2%
| T3 | 0% | 1,289 |
| cyclosporine, modified 100 MG/ML Oral Solution [Neoral] cyclosporine, modified | 99 | 2%
| T3 | 100% | 492,479 |
| budesonide 0.2 MG/ML Oral Suspension [Eohilia] budesonide | 99 | 2%
| T4 | 100% | 61,841 |
| mycophenolate mofetil 250 MG Oral Capsule [Cellcept] mycophenolate mofetil | 98 | 1.9%
| T4 | 100% | 105,503 |
| mycophenolate mofetil 500 MG Oral Tablet [Cellcept] mycophenolate mofetil | 98 | 1.9%
| T4 | 100% | 105,503 |
| baricitinib 4 MG Oral Tablet [Olumiant] baricitinib | 98 | 1.9%
| T3 | 100% | 1,389 |
| 24 HR oxcarbazepine 150 MG Extended Release Oral Tablet oxcarbazepine | 98 | 1.9%
| T3 | 0% | - |
| 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet oxcarbazepine | 98 | 1.9%
| T3 | 0% | - |
| 24 HR oxcarbazepine 600 MG Extended Release Oral Tablet oxcarbazepine | 98 | 1.9%
| T4 | 0% | - |
| digoxin 0.25 MG Oral Tablet [Lanoxin] digoxin | 97 | 1.9%
| T3 | 0% | 392,747 |
| liothyronine sodium 0.005 MG Oral Tablet [Cytomel] liothyronine sodium | 97 | 1.9%
| T3 | 0% | 171,270 |
| liothyronine sodium 0.025 MG Oral Tablet [Cytomel] liothyronine sodium | 97 | 1.9%
| T3 | 0% | 171,270 |
| liothyronine sodium 0.05 MG Oral Tablet [Cytomel] liothyronine sodium | 97 | 1.9%
| T3 | 0% | 171,270 |
| Modified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet Modified | 97 | 1.9%
| T3 | 25% | - |
| 1 ML ustekinumab-hmny 90 MG/ML Prefilled Syringe [Starjemza] ustekinumab-hmny | 96 | 1.9%
| T3 | 100% | - |
| bosentan 32 MG Tablet for Oral Suspension [Tracleer] bosentan | 95 | 1.9%
| T4 | 100% | 715 |
| prednisolone 10 MG Disintegrating Oral Tablet [Orapred] prednisolone | 94 | 1.9%
| T3 | 25% | 20,337 |